Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company offers prescription pharmaceuticals for cardiovascular, central nervous system, gastrointestinal tract, pain, diabetes, and other therapeutic areas. It also provides non-prescription products for cough, cold, cerebral, peripheral circulation, gastrointestinal tract, metabolism, and other therapeutic areas, as well as analgesics, vitamins, minerals, and vasoprotectives. In addition, the company offers animal health products, including antiparasitics, antimicrobials, and other products. Further, it provides health resort and tourist services. The company was founded in 1954 and is based in Novo Mesto, Slovenia.
Metrics to compare | KRKG | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipKRKGPeersSector | |
|---|---|---|---|---|
P/E Ratio | 18.3x | 18.7x | −0.5x | |
PEG Ratio | 1.32 | 0.11 | 0.00 | |
Price / Book | 3.1x | 1.6x | 2.6x | |
Price / LTM Sales | 3.6x | 1.5x | 3.2x | |
Upside (Analyst Target) | −12.5% | 5.2% | 47.4% | |
Fair Value Upside | Unlock | 16.9% | 6.9% | Unlock |